Obesity stocks gain on Biden's Medicare proposal
Investing.com -- The Biden administration has proposed a new rule requiring Medicare and Medicaid to cover weight loss medications for patients treating obesity. Announced on Tuesday, the measure would significantly expand access to drugs like Wegovy, Ozempic, and Mounjaro.
The research found disparities in access to weight loss drugs. Data from health analytics firm PurpleLab shows that 85% of semaglutide prescriptions, the active ingredient in Wegovy and Ozempic, were filled by white patients in 2023. Without insurance coverage, the high cost of these drugs poses a significant barrier for low- and middle-income individuals.“Our Medicare and Medicaid populations are some of the most at-risk and they do not have access to any anti-obesity medication,” Dr.
Weight loss drugs like Wegovy are injectable treatments containing semaglutide, a compound that mimics GLP-1, a hormone that regulates blood sugar, metabolism, and appetite. This expansion could reshape treatment options for millions while addressing health disparities and the economic barriers to managing obesity.Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Biden administration wants Medicare, Medicaid to cover anti-obesity medicinesJustin Boggs is a writer for the E.W. Scripps company. Justin covers anything from politics to sports and entertainment.
Read more »
Biden administration proposes expanding obesity drug coverage under Medicare and MedicaidAn estimated 42% of Americans struggle with obesity, the White House says.
Read more »
7.4 million Americans could gain Medicare or Medicaid coverage for anti-obesity drugs under Biden proposalMillions more senior citizens and lower-income Americans could obtain coverage for costly anti-obesity drugs under a proposal being unveiled Tuesday by the Biden administration.
Read more »
Countdown to Medicare Enrollment: 4 Essential Medicare Advantage Questions Answered for 2025Articles and videos about Countdown to Medicare Enrollment: 4 Essential Medicare Advantage Questions Answered for 2025 on FOX 10 Phoenix.
Read more »
Trump Picks Medicare Privatization Proponent Dr. Oz to Oversee Medicare AgencyFearless Independent Journalism
Read more »
Biden proposes Medicare and Medicaid cover costly weight-loss drugs for millions of obese AmericansMillions of obese Americans would be eligible to have popular weight-loss drugs like Wegovy or Ozempic covered by Medicare or Medicaid under a new rule the Biden administration proposed Tuesday morning.
Read more »